Revive Therapeutics Announces Proposed Private Placement and Debt Settlement - Revive Therapeutics (OTC:RVVTF)

Revive Therapeutics Announces Proposed Private Placement and Debt Settlement - Revive Therapeutics (OTC:RVVTF)

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to arrange a private placement offering of up to 30,952,381 units, at a price of $0.021 per unit, for gross proceeds to Revive of up to $650,000, and to settle $67,400 ow…

Revive Therapeutics Announces Proposed Private Placement and Debt Settlement

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to…

Revive Therapeutics Secures $650,000 Private Placement at $0.021 with 3-Year Warrants

Revive Therapeutics announces $650K private placement at $0.021 per unit, includes warrants at $0.05. Plus $67.4K debt settlement. See full financing details.